TAK compared with GLXY: revenue, margins and what each company keeps, and the suppliers and customers both name

TAKTakeda Pharmaceutical Co Ltd

Mkt capRevenueRevenue

GLXYGalaxy Digital Inc.

Mkt capRevenueRevenue

Compare

TAKTakeda Pharmaceutical Co Ltd

GLXYGalaxy Digital Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TAK 17

NBIXNeurocrine Biosciencescustomer

EXELExelixissupplier

PTGXProtagonist Therapeuticssupplier

DNLIDenali Therapeuticssupplier

13 more · TAK chain ›

Shared 0

No shared counterparties.

Only GLXY 16

MSFTMicrosoft Azuresupplier

AMZNAmazon Web Servicessupplier

CRWVCoreWeavecustomer

SLNHSolunasupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

12 more · GLXY chain ›

TAKTakeda Pharmaceutical Co Ltd

20.83▼−0.40%

Mkt cap$36.0BRevenue—Revenue—

GLXYGalaxy Digital Inc.

15.58▼−2.60%

Regular sessionSep 2 '83

Mkt cap$3.1BRevenue$8.7BQ2 FY26Revenue$74.2BFY25

Compare

Regular sessionSep 2 '83

TAKTakeda Pharmaceutical Co Ltd

GLXYGalaxy Digital Inc.

20.83▼−0.40%

Price

15.58▼−2.60%

$36.0B

Mkt cap

$3.1B

—

Revenue

$8.7BQ2 FY26

—

Revenue

$74.2BFY25

TAK20.83▼−0.40%vsGLXY15.58▼−2.60%Regular sessionSep 2 '83